受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:D4051 Batch: D405101
Tisotumab vedotin (TF-011-MMAE, HuMax-TF-ADC) is an antibody-drug conjugate (ADC) composed of a fully human monoclonal antibody to tissue factor III (thromboplastin) also known as CD142, conjugated to Monomethyl Auristatin E (MMAE), via a cleavable maleimidocaproyl-valyl-citrullinylp-aminobenzyloxycarbonyl (mc-val-cit-PABC) type linker. Tisotumab vedotin has the potential for use in research of solid tumors mainly in cervical cancer.
CAS No. | 1418731-10-8 |
---|---|
Formulation | 1xPBS |
DAR | 4.2 |
ADC antiody | Tisotumab |
ADC cytotoxin | MMAE |
Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
Shipping | Shipped under low temperature conditions |
Purity | 98% |
Protein concentration | 9.88mg/ml |
Endotoxin Level | <1EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。